James, N D <br/><br/>
Response to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al.  [electronic resource] 

 -  Clinical oncology (Royal College of Radiologists (Great Britain))  10 2016 
 - 666-7 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1433-2981 
<br/><br/><label>Standard No.: </label>10.1016/j.clon.2016.07.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols<br/>Docetaxel<br/>Humans<br/>Male<br/>Neutropenia<br/>Prostatic Neoplasms<br/>Taxoids